Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 14.3%Low 0 · 0%Moderate 6 · 85.7%High 0 · 0%

Annualized spontaneous Bleeding Rate (AsBR) · people without inhibitors

1 finding from 1 review

Non‐clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 119 participants
Moderate

Annualized spontaneous Bleeding Rate (AsBR) · people with inhibitors

1 finding from 1 review

Non‐clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 57 participants
Moderate

Annualized spontaneous Bleeding Rate (AsBR) · people with inhibitors

1 finding from 1 review

Non‐clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B 2024 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 78 participants
Very low

Annualized spontaneous Bleeding Rate (AsBR) · people with inhibitors

1 finding from 1 review

Non‐clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 53 participants
Moderate

Annualized spontaneous Bleeding Rate (AsBR) · people without inhibitors

1 finding from 1 review

Non‐clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 71 participants
Moderate

Annualized spontaneous Bleeding Rate (AsBR) · people without inhibitors

1 finding from 1 review

Non‐clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 54 participants
Moderate

Annualized spontaneous Bleeding Rate (AsBR) · people without inhibitors

1 finding from 1 review

Non‐clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 53 participants
Moderate